Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria J Merino

Showing results (211-220 of 296) with videos related to

Pageof 30
Sort By:
JAMA|January 28, 2015
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancerM Minhaj Siddiqui, Soroush Rais-Bahrami, Baris Turkbey, et al.
Human Molecular Genetics|November 11, 2025
Tuberous sclerosis complex-associated renal cell carcinoma, an underappreciated form of familial renal cancer, is characterized by activation of the TFEB/TFE3 pathwayChristopher J Ricketts, Cathy D Vocke, Martin Lang, et al.
European Journal of Radiology|September 17, 2023
Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRIEnis C Yilmaz, Stephanie A Harmon, Mason J Belue, et al.
Urologic Oncology|August 12, 2015
Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomyBerrend G Muller, Aradhana Kaushal, Sandeep Sankineni, et al.
BMC Cancer|November 28, 2014
Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1Meghan L Rudd, Hassan Mohamed, Jessica C Price, et al.
AJR. American Journal of Roentgenology|July 5, 2023
Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyKatie M Merriman, Stephanie A Harmon, Mason J Belue, et al.
The Journal of Urology|September 28, 2011
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based moldsBaris Turkbey, Haresh Mani, Vijay Shah, et al.
The Lancet. Oncology|January 24, 2018
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 studyJung-Min Lee, Jayakumar Nair, Alexandra Zimmer, et al.
The Journal of Urology|August 14, 2014
Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsyNabeel A Shakir, Arvin K George, M Minhaj Siddiqui, et al.
European Urology|June 22, 2013
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsyM Minhaj Siddiqui, Soroush Rais-Bahrami, Hong Truong, et al.
Pageof 30

Showing results (211-220 of 296) with videos related to

Sort By:
Pageof 30
JAMA|January 28, 2015
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancerM Minhaj Siddiqui, Soroush Rais-Bahrami, Baris Turkbey, et al.
Human Molecular Genetics|November 11, 2025
Tuberous sclerosis complex-associated renal cell carcinoma, an underappreciated form of familial renal cancer, is characterized by activation of the TFEB/TFE3 pathwayChristopher J Ricketts, Cathy D Vocke, Martin Lang, et al.
European Journal of Radiology|September 17, 2023
Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRIEnis C Yilmaz, Stephanie A Harmon, Mason J Belue, et al.
Urologic Oncology|August 12, 2015
Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomyBerrend G Muller, Aradhana Kaushal, Sandeep Sankineni, et al.
BMC Cancer|November 28, 2014
Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1Meghan L Rudd, Hassan Mohamed, Jessica C Price, et al.
AJR. American Journal of Roentgenology|July 5, 2023
Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyKatie M Merriman, Stephanie A Harmon, Mason J Belue, et al.
The Journal of Urology|September 28, 2011
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based moldsBaris Turkbey, Haresh Mani, Vijay Shah, et al.
The Lancet. Oncology|January 24, 2018
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 studyJung-Min Lee, Jayakumar Nair, Alexandra Zimmer, et al.
The Journal of Urology|August 14, 2014
Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsyNabeel A Shakir, Arvin K George, M Minhaj Siddiqui, et al.
European Urology|June 22, 2013
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsyM Minhaj Siddiqui, Soroush Rais-Bahrami, Hong Truong, et al.
Pageof 30